Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iron Chelation”

80 trials

Showing 20 of 80 results

Not applicableStudy completedNCT06509581
What this trial is testing

Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen

Who this might be right for
Beta-Thalassemia
Ain Shams University 180
Large-scale testing (Phase 3)Study completedNCT01825512
What this trial is testing

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Who this might be right for
Chronic Iron Overload
Consorzio per Valutazioni Biologiche e Farmacologiche 435
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Not applicableStudy completedNCT01623895
What this trial is testing

Pharmacogenetic Study in Patients Received Iron Chelating Agent

Who this might be right for
Hemosiderosis
Seoul National University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Post-approval studies (Phase 4)Study completedNCT00749515
What this trial is testing

Pilot Study for Patients With Poor Response to Deferasirox

Who this might be right for
Transfusion-dependent HemachromatosisThalassemia MajorSickle Cell Disease
Boston Children's Hospital 15
Large-scale testing (Phase 3)UnknownNCT01511848
What this trial is testing

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Who this might be right for
Beta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis
Ain Shams University 60
Large-scale testing (Phase 3)Study completedNCT00171821
What this trial is testing

A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload

Who this might be right for
Transfusion-dependent Iron Overload
Novartis Pharmaceuticals 1,784
Testing effectiveness (Phase 2)Study completedNCT01539837
What this trial is testing

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Imperial College London 22
Testing effectiveness (Phase 2)Study completedNCT00940602
What this trial is testing

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 225
Large-scale testing (Phase 3)Study completedNCT03293069
What this trial is testing

Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Lille 372
Not applicableStudy completedNCT05440487
What this trial is testing

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 489
Large-scale testing (Phase 3)Study completedNCT00171210
What this trial is testing

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload in β-thalassemia
Novartis Pharmaceuticals 506
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Early research (Phase 1)Study completedNCT00004982
What this trial is testing

Combination Iron Chelation Therapy

Who this might be right for
Iron OverloadThalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT01709032
What this trial is testing

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Who this might be right for
Thalassemia Major With Severe Transfusional Iron Overload
Children's Hospital of Philadelphia 9
Testing effectiveness (Phase 2)Study completedNCT00224640
What this trial is testing

Iron-Chelating Therapy and Friedreich Ataxia

Who this might be right for
Friedreich Ataxia
Assistance Publique - Hôpitaux de Paris 15
Not applicableLooking for participantsNCT06781099
What this trial is testing

Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis

Who this might be right for
Myelodysplastic SyndromeMyelofibrosis
Hospices Civils de Lyon 13
Testing effectiveness (Phase 2)Study completedNCT00379483
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 66
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation